Loading component ...

Snoozeal®

Loading component ...

Including Tax

Loading component ...

Spread your payments over 6 to 36 months with 0% finance from Klarna

Klarnaunited kingdom flag

E.g. Pay £24.38 per month in 24 monthly instalments

• Interest-free instalments, automatically charged from your card every 30 days
• No interest or fees when you pay on time
• Select Klarna at the checkout “payment” stage and enter your credit or debit card
• Super-simple signup
• Only available in the UK

The daytime therapy for snoring. Clinically proven 1-3, effective and easy to use at home. Available to buy in the UK, EU and Canada.

Not currently available in the USA.

The Snoozeal® device will deliver small electric currents through the mouthpiece to your tongue, this will stimulate the tongue muscle and improve its tone. The improved tone of the tongue muscle will help in keeping the breathing passage open during your sleep and reduce the vibration of the throat region.

Contraindications

Do not use Snoozeal if:

  • You are pregnant or may be pregnant
  • You have a pacemaker or implanted electrodes
  • You have temporary or permanent implants, dental braces or jewellery in your mouth
  • You are suffering from mouth ulceration
  • You have or are suspected of having sleep apnoea with an AHI of greater than 15
  • Safety and effectiveness in the above conditions has not been established.
  • Read all instructions before use

Our Snoozeal® box includes:

  • Control unit
  • Mouthpiece
  • Remote control (in selected models only)
  • USB charging cable
  • User instructions

Further information can be found on the Snoozeal website in the frequently asked questions section.

1. E.Wessoleck et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22(Suppl 2): 47–52.
2. A.Sama et al. Daytime Intraoral Neurostimulation with Snoozeal® for treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes, 2018.
3. Prospective cohort study of 50 patients with snoring or mild OSA (Apnea- Hypopnea Index (AHI) <15) with 46 completed the trial. Objective snoring and respiratory parameters were recorded with 2 consecutive WatchPat night sleep studies before and after the use of the device. An intra-oral tongue stimulator (Snoozeal®) device was used for 20mins, once a day for 6-week period.

Last updated June 2020.

Watch the trailer

how snoozeal works - hand with device

With improved sleep quality comes better health, better lives and closer relationships

References

  1. White DP, Sleep-related breathing disorder: 2-pathophysiology of obstructive sleep apnoea. Thorax. 1995; 50:797-804. [PubMed: 7570420]
  2. Peppard PE, Young T, Palta M et al. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000; 1378-1384. [PubMEd: 10805822]
  3. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122:352-360. [PubMed: 20625114]
  4. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034-2041. [PubMed: 16282178]
  5. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: The Sleep Heart Health Study. AM J Respir Crit Care Med. 2010; 182:269-277. [PubMed: 20339144]
  6. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. AM J Repir Crit Care Med. 2002; 166:159-165. [PubMed: 12119227]
  7. Marin JM, Carrizo SJ, Vicente E, et al Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365:1046-1053. [PubMed: 15781100]
  8. Peppard PE, Szklo-Coxe M, Hla KM, et al. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med. 2006; 166:1709-1715. [PubMed: 16983048]
  9. Kendzerska T, Gershon AS, Hawker G, et al. Obstructive sleep apnea and incident diabetes: a historical cohort study. AM J Respir Crit Care Med. 2014; 190:218-225. [PubMed: 24897551]
  10. E.Wessoleck et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22(Suppl 2): 47–52.
  11. A.Sama et al. Daytime Intraoral Neurostimulation with Snoozeal® for treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes, 2018
  12. Prospective cohort study of 50 patients with snoring or mild OSA (Apnea- Hypopnea Index (AHI) <15) with 46 completed the trial. Objective snoring and respiratory parameters were recorded with 2 consecutive WatchPat night sleep studies before and after the use of the device. An intra-oral tongue stimulator (Snoozeal®) device was used for 20mins, once a day for 6-week period